St. Jude's next-gen heart defibrillators gain CE mark

05/10/2013 | RTT News

St. Jude Medical has earned the CE mark in Europe to market its Ellipse and SJM Assura implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators. The devices automatically adjust voltage in the event of an electrical short and help reduce risk for lead abrasion.

View Full Article in:

RTT News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX